Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 61

Wish comes true in $1.1bn IPO

The mobile commerce platform developer priced its initial public offering at the top of its range, with JD.com set to exit in the flotation.

Dec 16, 2020

Innoviz joins Collective for $1.4bn reverse merger

Phoenix Insurance and Magna International are among the backers of a $200m PIPE investment as the lidar sensor provider prepares to list on Nasdaq.

Dec 16, 2020

Blade cuts to reverse merger deal

The Airbus Helicopters-backed air transport service will go public through the deal, with the combined company to be valued at $825m.

Dec 16, 2020

AbCellera accomplishes $483m initial public offering

Shares in the antibody discovery platform developer, advancing UBC research, opened at more than three times their IPO price to net it a valuation topping $15bn.

Dec 14, 2020

AbCellera accomplishes $483m initial public offering

The Eli Lilly-backed antibody discovery platform developer's shares opened at more than three times their IPO price to net it a valuation topping $15bn.

Dec 14, 2020

Analysis: DoorDash goes public in $3.37bn IPO

The company priced an upsized IPO nearly doubling its valuation six months ago. It is part of a the food delivery space which was given a boost by the pandemic.

Dec 14, 2020

Medirom seeks healthy returns in US IPO

The CCC Marketing-backed salon operator has set a range for an initial public offering set to net it between $16.8m and $19.2m.

Dec 11, 2020

Airbnb aces IPO to raise $3.49bn

The Alphabet-backed accommodation marketplace priced its initial public offering well above its range in the second huge flotation this week, to secure a $47bn valuation.

Dec 10, 2020

DoorDash lets in $3.37bn through IPO

SoftBank Vision Fund is the largest investor in the food delivery service, which has priced an upsized initial public offering roughly doubling its valuation six months ago.

Dec 9, 2020

Silverback swells IPO to near $278m

The underwriters have taken up the over-allotment option in BMS and Celgene-backed oncology drug developer Silverback's initial public offering.

Dec 9, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here